Page 115 - Color_Atlas_of_Physiology_5th_Ed._-_A._Despopoulos_2003
P. 115

Hemostasis                      I   Fibrinogen     Half-life (h): 96
                                       II  K  Prothrombin         72
       The hemostatic system stops bleeding. Throm-
       bocytes (platelets), coagulation (or clotting) fac-  III  Tissue thromboplastin
                                                      2+
       tors in plasma and vessel walls interact to seal  IV  Ionized calcium (Ca )
       leaks in blood vessels. The damaged vessel  V  Proaccelerin  20
       constricts (release of endothelin), and platelets  VII  K  Proconvertin  5
       aggregate at the site of puncture (and attract  VIII  Antihemophilic factor A  12
       more platelets) to seal the leak by a platelet  IX  K  Antihemophilic factor B; plasma
       plug. The time required for sealing (ca. 2 to 4  thromboplastin component (PTC);
       min) is called the bleeding time. Subsequently,  Christmas factor  24
       the coagulation system produces a fibrin  X  K  Stuart–Prower factor  30
       meshwork. Due to covalent cross-linking of fi-  XI  Plasma thromboplastin antecedent
       brin, it turns to a fibrin clot or thrombus that re-  (PTA)  48
       tracts afterwards, thus reinforcing the seal.  XII  Hageman factor  50
       Later recanalization of the vessel can be  XIII  Fibrin-stabilizing factor (FSF)  250
       achieved by fibrinolysis.       –   Prekallikrein (PKK); Fletcher factor
         Platelets (170–400 · 10 3  per µL of blood;  –  High-molecular-weight kininogen
       half-life ! 10 days) are small non-nucleated  (HMK); Fitzgerald factor
       bodies that are pinched off from megakaryo-
    Blood  cytes in the bone marrow. When an en-  Several coagulation factors are involved in
                                                             2+
    4  dothelial injury occurs, platelets adhere to  the clotting process. Except for Ca , they are
       subendothelial collagen fibers (! A1) bridged
       by von Willebrand’s factor (vWF), which is  proteins formed in the liver (! B and Table).
                                       Factors labeled with a “K” in the table (as well
       formed by endothelial cells and circulates in  as protein C and protein S, see below) are pro-
       the plasma complexed with factor VIII. Glyco-  duced with vitamin K, an essential cofactor in
       protein complex GP Ib/IX on the platelets are  posttranslational γ-carboxylation of gluta-
       vWF receptors. This adhesion activates plate-  mate residues of the factors. These γ-carboxy-
       lets (! A2). They begin to release substances  glutamyl groups are chelators of Ca . They are
                                                             2+
       (! A3), some of which promote platelet adhe-  required for Ca -mediated complex forma-
                                                 2+
       siveness (vWF). Others like serotonin, plate-  tion of factors on the surface of phospholipid
       let-derived  growth  factor  (PDGF)  and  layers (PL), particularly on the platelet mem-
       thromboxane A 2 (TXA 2) promote vasoconstric-  brane (platelet factor 3). Vitamin K is oxidized
       tion. Vasoconstriction and platelet contraction  in the reaction and has to be re-reduced by
       slow the blood flow. Mediators released by  liver epoxide reductase (vitamin K recycling).
       platelets enhance platelet activation and at-  Ca 2+  ions are required for several steps in the
       tract and activate more platelets: ADP, TXA 2,  clotting process (! B). When added to blood
       platelet-activating factor (PAF). The shape of  samples in vitro, citrate, oxalate, and EDTA
       activated platelets change drastically (! A4).  bind with Ca 2+  ions, thereby preventing the
       Discoid platelets become spherical and exhibit  blood from clotting. This effect is desirable
       pseudopodia that intertwine with those of  when performing various blood tests.
       other platelets. This platelet aggregation  Activation of blood clotting (! B). Most coagu-
       (! A5) is further enhanced by thrombin and  lation factors normally are not active, or zymo-
       stabilized by GP IIb/IIIa. Once a platelet  genic. Their activation requires a cascade of
       changes its shape, GP IIb/IIIa is expressed on  events (An “a” added to the factor number
       the platelet surface, leading to fibrinogen  means “activated”). Thus, even small amounts
       binding and platelet aggregation. GP IIb/IIIa  of a trigger factor lead to rapid blood clotting.
       also increases the adhesiveness of platelets,  The trigger can be endogenous (within a ves-
       which makes it easier for them to stick to sub-  sel) or exogenous (external). Endogenous acti-
       endothelial fibronectin.
  102                                  vation (! B2) occurs at an endothelial defect.
                                       XII is activated to XIIa by the contact with
                                                                   !
       Despopoulos, Color Atlas of Physiology © 2003 Thieme
       All rights reserved. Usage subject to terms and conditions of license.
   110   111   112   113   114   115   116   117   118   119   120